BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12879891)

  • 1. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Aberegg SK
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879891
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    van Dongen CJ; Prins MH; Büller HR
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12878749
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Cosmi B; Palareti G
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879889
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Seneviratne C; Kupfer Y; Tessler S
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879892
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Krishnan JA; Streiff MB
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Brotman DJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Malik V; Kupfer Y; Tessler S
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Glynn RJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

  • 11. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term prophylaxis after venous thromboembolism].
    Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
    Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary prophylaxis with warfarin for venous thromboembolism.
    Büller HR; Prins MH
    N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
    Abdel-Razeq HN; Radwi GR
    Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Stern SD
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699650
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Paul N
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14695423
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Gelber AC; Saleh AS
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.